Imagine moving from a diagnosis of “severe” autism to no longer meeting the criteria for autism spectrum disorder (ASD).  The recently completed Microbiota Transplant Therapy (MTT) Phase 1 study indicates such results are possible and sustainable.  

At the beginning of the study, 83% of participants were classified as “severe” on an autism diagnosis scale. At a 2 year follow up, only 17% were still “severe”, and 44% no longer met the criteria for an autism diagnosis. Most participants had significant improvements in core autism symptoms and gastrointestinal problems. 

View Full Article

You need to login or register to bookmark/favorite this content.